|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.130 USD | +0.89% |
|
+4.63% | -81.54% |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 27.04M 23.42M 21.83M 20.08M 37.9M 2.57B 38.32M 257M 101M 1.29B 102M 99.3M 4.26B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 27.04M 23.42M 21.83M 20.08M 37.9M 2.57B 38.32M 257M 101M 1.29B 102M 99.3M 4.26B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.89% | ||
| 1 week | +4.63% | ||
| Current month | +1.80% | ||
| 1 month | -25.66% | ||
| 3 months | -63.19% | ||
| 6 months | -73.84% | ||
| Current year | -81.54% |
| 1 week | 1.02 |  | 1.22 |
| 1 month | 1.02 | | 1.95 |
| Current year | 1.02 | | 7.05 |
| 1 year | 1.02 | | 9.22 |
| 3 years | 1.02 | | 11.99 |
| 5 years | 1.02 | | 11.99 |
| 10 years | 1.02 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 28/02/2015 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 31/01/2024 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
BRD | Director/Board Member | 64 | 31/03/2015 |
Aaron Fletcher
CHM | Chairman | 46 | 31/03/2015 |
Daniel Zabrowski
BRD | Director/Board Member | 66 | 28/02/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/02/26 | Fiscal year | Chief Executive Officer | 665,984 | 2.8653% | ||
| 05/01/26 | Kairos Venture Investments LLC
| Sell | Company | 280,000 | 1.2046% | |
| 27/06/25 | BIOS Capital Management LP
| Buy | Company | 71,428 | 0.3657% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.89% | +4.63% | -84.54% | - | 27.04M | |
| +4.35% | +16.60% | +58.11% | +95.21% | 64.9B | |
| +2.32% | +2.54% | +31.41% | +73.17% | 54.05B | |
| +0.91% | -0.83% | -17.01% | -13.43% | 23.16B | |
| +0.27% | -3.98% | -11.28% | +350.30% | 21.46B | |
| +1.87% | +9.47% | +30.87% | -5.63% | 21.25B | |
| +0.62% | +3.36% | +38.42% | -24.99% | 17.94B | |
| +9.88% | +23.61% | +222.87% | +385.49% | 17.03B | |
| +3.29% | +5.61% | +21.01% | +636.23% | 14.99B | |
| +1.25% | +2.48% | +51.36% | +179.72% | 14.25B | |
| Average | +2.56% | +4.99% | +34.12% | +186.23% | 24.91B | |
| Weighted average by Cap. | +2.88% | +5.90% | +44.24% | +142.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | US$1.130 | +0.89% | 176,619 |
| 04/08/26 | US$1.120 | +5.66% | 309,766 |
| 03/08/26 | US$1.060 | -4.50% | 174,798 |
| 31/07/26 | US$1.110 | -5.13% | 157,074 |
| 30/07/26 | US$1.170 | +8.33% | 269,388 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.130USD
Average target price
9.978USD
Spread / Average Target
+782.96%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
